Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RT8M
|
|||
| Drug Name |
PMID25656651-Compound-28b
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ZHANG, Dawei
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C29H30FN7O
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1F)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
|
|||
| InChI |
1S/C29H30FN7O/c1-20-25(30)16-24(17-27(20)35-29-32-11-9-26(34-29)23-4-3-10-31-18-23)33-28(38)22-7-5-21(6-8-22)19-37-14-12-36(2)13-15-37/h3-11,16-18H,12-15,19H2,1-2H3,(H,33,38)(H,32,34,35)
|
|||
| InChIKey |
ZRPUCWORBBVKGL-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.